P2.01. An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Ashley Horne
Meta Tag
Speaker Ashley Horne
Topic Local-Regional NSCLC: Novel Therapies & Trials
phase Ib platform study
novel agents
conventional radiotherapy
non-small cell lung cancer
adaptive Bayesian model-based approach
dose escalation
consolidation durvalumab
safety assessment
recommended phase II dose
Powered By